MaRVis Technologies GmbH

PRESS RELEASE 2011-08-29 (MR Micro-Guidewire) ...more

PRESS RELEASE 2011-05-06 (Novel Imaging Technique) ...more

PRESS RELEASE 2011-02-09 (Groundbreaking improvements) ...more

Press Release 2010-06-24 (Proof-of-concept achieved) ...more

Article about MaRVis Technologies GmbH ...more

More News »

INVESTORS

MaRVis has attracted The BioScience Ventures Group AG (Munich, Germany) and Seed Fonds für die Region Aachen GmbH & Co. KG (Aachen, Germany) as seed investors.

The BioScience Ventures Group AG is a venture capital investor with an exclusive focus on early stage life science investments. The BSVG team provides a strong background and experience in biotechnology, pharma and medical technology as well as legal and investment affairs.

Seed Fonds Aachen has been incorporated in 2007 by Sparkasse Aachen, private investors and NRW. Bank as a new investment fund with a regional focus. This fund supports innovative companies and entrepreneurs with promising ideas and strong growth potential.